Evolent Health Inc (NYSE:EVH) insider Lydia Stone sold 6,805 shares of the firm’s stock in a transaction that occurred on Thursday, August 30th. The stock was sold at an average price of $25.00, for a total transaction of $170,125.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

EVH opened at $24.50 on Friday. Evolent Health Inc has a one year low of $10.30 and a one year high of $25.82. The company has a current ratio of 2.59, a quick ratio of 2.59 and a debt-to-equity ratio of 0.12. The company has a market cap of $1.92 billion, a PE ratio of -35.00 and a beta of 1.22.

Evolent Health (NYSE:EVH) last released its quarterly earnings results on Tuesday, August 7th. The technology company reported ($0.03) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.04) by $0.01. Evolent Health had a negative net margin of 9.84% and a negative return on equity of 1.82%. The business had revenue of $144.51 million for the quarter, compared to analysts’ expectations of $141.90 million. equities analysts anticipate that Evolent Health Inc will post -0.34 EPS for the current fiscal year.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. grew its stake in shares of Evolent Health by 16.1% during the second quarter. BlackRock Inc. now owns 4,362,231 shares of the technology company’s stock valued at $91,823,000 after purchasing an additional 605,714 shares during the last quarter. Riverbridge Partners LLC grew its stake in shares of Evolent Health by 25.6% during the second quarter. Riverbridge Partners LLC now owns 3,536,179 shares of the technology company’s stock valued at $74,437,000 after purchasing an additional 719,956 shares during the last quarter. Millennium Management LLC grew its stake in shares of Evolent Health by 12.9% during the first quarter. Millennium Management LLC now owns 3,179,977 shares of the technology company’s stock valued at $45,315,000 after purchasing an additional 363,191 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Evolent Health by 45.1% during the second quarter. Dimensional Fund Advisors LP now owns 2,818,720 shares of the technology company’s stock valued at $59,335,000 after purchasing an additional 876,358 shares during the last quarter. Finally, Eagle Asset Management Inc. grew its stake in shares of Evolent Health by 29.3% during the second quarter. Eagle Asset Management Inc. now owns 2,574,180 shares of the technology company’s stock valued at $54,186,000 after purchasing an additional 582,666 shares during the last quarter.

Several analysts have recently weighed in on EVH shares. SunTrust Banks raised their price objective on shares of Evolent Health and gave the stock a “buy” rating in a report on Thursday, June 7th. Zacks Investment Research raised shares of Evolent Health from a “hold” rating to a “buy” rating and set a $21.00 price objective for the company in a report on Monday, May 14th. Piper Jaffray Companies started coverage on shares of Evolent Health in a report on Monday, June 4th. They set an “overweight” rating and a $30.00 price objective for the company. KeyCorp raised their price objective on shares of Evolent Health from $26.00 to $28.00 and gave the stock an “overweight” rating in a report on Monday, August 20th. Finally, Jefferies Financial Group reaffirmed a “buy” rating and set a $25.00 price objective on shares of Evolent Health in a report on Tuesday, August 7th. One equities research analyst has rated the stock with a sell rating and fourteen have assigned a buy rating to the company. Evolent Health currently has a consensus rating of “Buy” and a consensus target price of $26.92.

Evolent Health Company Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management.

Featured Article: Trading Strategy Methods and Types

Insider Buying and Selling by Quarter for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.